Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Edison Investment Research Limited: Edison issues outlook on Basilea Pharmaceutica (BSLN)

Edison Investment Research Limited: Edison issues outlook on Basilea Pharmaceutica (BSLN)

Edison Investment Research Limited: Edison issues outlook on Basilea Pharmaceutica (BSLN)

0

DGAP-News: 4SC AG enters into avelumab supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer for clinical combination study of domatinostat in Merkel cell carcinoma

DGAP-News: 4SC AG enters into avelumab supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer for clinical combination study of domatinostat in Merkel cell carcinoma

DGAP-News: 4SC AG enters into avelumab supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer for clinical combination study of domatinostat in Merkel cell carcinoma

0

DGAP-News: 4SC AG schließt Liefervereinbarung mit Merck KGaA, Darmstadt, Germany und Pfizer für Avelumab für klinische Kombinationsstudie mit Domatinostat im Merkelzellkarzinom ab

DGAP-News: 4SC AG schließt Liefervereinbarung mit Merck KGaA, Darmstadt, Germany und Pfizer für Avelumab für klinische Kombinationsstudie mit Domatinostat im Merkelzellkarzinom ab

DGAP-News: 4SC AG schließt Liefervereinbarung mit Merck KGaA, Darmstadt, Germany und Pfizer für Avelumab für klinische Kombinationsstudie mit Domatinostat im Merkelzellkarzinom ab

0

DGAP-News: EVOTEC UND BRISTOL-MYERS SQUIBB ERWEITEREN IPSC-ALLIANZ: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC UND BRISTOL-MYERS SQUIBB ERWEITEREN IPSC-ALLIANZ

DGAP-News: EVOTEC UND BRISTOL-MYERS SQUIBB ERWEITEREN IPSC-ALLIANZ

0

DGAP-News: EVOTEC AND BRISTOL-MYERS SQUIBB EXPAND IPSC COLLABORATION: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC AND BRISTOL-MYERS SQUIBB EXPAND IPSC COLLABORATION

DGAP-News: EVOTEC AND BRISTOL-MYERS SQUIBB EXPAND IPSC COLLABORATION

0

DGAP-News: Vivoryon Therapeutics AG: Vivoryon Therapeutics to Attend 38th Annual J.P. Morgan Healthcare Conference in January 2020

DGAP-News: Vivoryon Therapeutics AG: Vivoryon Therapeutics to Attend 38th Annual J.P. Morgan Healthcare Conference in January 2020

DGAP-News: Vivoryon Therapeutics AG: Vivoryon Therapeutics to Attend 38th Annual J.P. Morgan Healthcare Conference in January 2020

0

Pharnext Announces Encouraging Data from Open-Label Phase 3 Extension Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A (CMT1A)

Pharnext Announces Encouraging Data from Open-Label Phase 3 Extension Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A (CMT1A)

Pharnext Announces Encouraging Data from Open-Label Phase 3 Extension Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A (CMT1A)

0

Form 8.3 - The Vanguard Group, Inc.: Allergan plc

Form 8.3 - The Vanguard Group, Inc.: Allergan plc

Form 8.3 - The Vanguard Group, Inc.: Allergan plc

0

Form 8.3 - The Vanguard Group, Inc.: AbbVie plc

Form 8.3 - The Vanguard Group, Inc.: AbbVie plc

Form 8.3 - The Vanguard Group, Inc.: AbbVie plc

0

DGAP-News: Biofrontera AG: Biofrontera verstärkt kommerzielle Ausrichtung mit Neuorganisation des USA-Geschäfts

DGAP-News: Biofrontera AG: Biofrontera verstärkt kommerzielle Ausrichtung mit Neuorganisation des USA-Geschäfts

DGAP-News: Biofrontera AG: Biofrontera verstärkt kommerzielle Ausrichtung mit Neuorganisation des USA-Geschäfts

0

DGAP-News: Biofrontera AG: Biofrontera strengthens commercial focus with reorganization of its US business

DGAP-News: Biofrontera AG: Biofrontera strengthens commercial focus with reorganization of its US business

DGAP-News: Biofrontera AG: Biofrontera strengthens commercial focus with reorganization of its US business

0

Form 8.3 - The Vanguard Group, Inc.: Allergan plc

Form 8.3 - The Vanguard Group, Inc.: Allergan plc

Form 8.3 - The Vanguard Group, Inc.: Allergan plc

0

Form 8.3 - The Vanguard Group, Inc.: AbbVie plc

Form 8.3 - The Vanguard Group, Inc.: AbbVie plc

Form 8.3 - The Vanguard Group, Inc.: AbbVie plc

0

Correction of a release from 02.01.2020, 09:55 CET/CEST - Sartorius Stedim Biotech SA: ANNUAL REPORT OF THE LIQUIDITY CONTRACT WITH THE STOCKBROKER COMPANY GILBERT DUPONT

Correction of a release from 02.01.2020, 09:55 CET/CEST - Sartorius Stedim Biotech SA: ANNUAL REPORT OF THE LIQUIDITY CONTRACT WITH THE STOCKBROKER COMPANY GILBERT DUPONT

Correction of a release from 02.01.2020, 09:55 CET/CEST - Sartorius Stedim Biotech SA: ANNUAL REPORT OF THE LIQUIDITY CONTRACT WITH THE STOCKBROKER COMPANY GILBERT DUPONT

0

Form 8.3 - The Vanguard Group, Inc.: AbbVie plc

Form 8.3 - The Vanguard Group, Inc.: AbbVie plc

Form 8.3 - The Vanguard Group, Inc.: AbbVie plc

0

Form 8.3 - The Vanguard Group, Inc.: Allergan plc

Form 8.3 - The Vanguard Group, Inc.: Allergan plc

Form 8.3 - The Vanguard Group, Inc.: Allergan plc

0

DGAP-News: EVOTEC NIMMT AN INVESTORENKONFERENZEN TEIL: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC NIMMT AN INVESTORENKONFERENZEN TEIL

DGAP-News: EVOTEC NIMMT AN INVESTORENKONFERENZEN TEIL

0

DGAP-News: EVOTEC TO ATTEND UPCOMING INVESTOR CONFERENCES: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

DGAP-News: EVOTEC TO ATTEND UPCOMING INVESTOR CONFERENCES

DGAP-News: EVOTEC TO ATTEND UPCOMING INVESTOR CONFERENCES

0

Sartorius Stedim Biotech SA: ANNUAL REPORT OF THE LIQUIDITY CONTRACT WITH THE STOCKBROKER COMPANY GILBERT DUPONT

Sartorius Stedim Biotech SA: ANNUAL REPORT OF THE LIQUIDITY CONTRACT WITH THE STOCKBROKER COMPANY GILBERT DUPONT

Sartorius Stedim Biotech SA: ANNUAL REPORT OF THE LIQUIDITY CONTRACT WITH THE STOCKBROKER COMPANY GILBERT DUPONT

0

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL

0

Form 8.3 - The Vanguard Group, Inc.: Allergan plc

Form 8.3 - The Vanguard Group, Inc.: Allergan plc

Form 8.3 - The Vanguard Group, Inc.: Allergan plc

0

Form 8.3 - The Vanguard Group, Inc.: AbbVie plc

Form 8.3 - The Vanguard Group, Inc.: AbbVie plc

Form 8.3 - The Vanguard Group, Inc.: AbbVie plc

0

DGAP-News: MagForce AG announces successful capital increase of the subsidiary MagForce USA, Inc.

DGAP-News: MagForce AG announces successful capital increase of the subsidiary MagForce USA, Inc.

DGAP-News: MagForce AG announces successful capital increase of the subsidiary MagForce USA, Inc.

0

DGAP-News: MagForce AG gibt erfolgreiche Kapitalerhöhung der US-Tochtergesellschaft MagForce USA, Inc. bekannt

DGAP-News: MagForce AG gibt erfolgreiche Kapitalerhöhung der US-Tochtergesellschaft MagForce USA, Inc. bekannt

DGAP-News: MagForce AG gibt erfolgreiche Kapitalerhöhung der US-Tochtergesellschaft MagForce USA, Inc. bekannt

0

DGAP-Adhoc: MagForce AG gibt erfolgreiche Kapitalerhöhung der US-Tochtergesellschaft MagForce USA, Inc. bekannt

DGAP-Adhoc: MagForce AG gibt erfolgreiche Kapitalerhöhung der US-Tochtergesellschaft MagForce USA, Inc. bekannt

DGAP-Adhoc: MagForce AG gibt erfolgreiche Kapitalerhöhung der US-Tochtergesellschaft MagForce USA, Inc. bekannt

0